Aker BioMarine ASA – Satisfaction of conditions for exercise of call option

25 Mar 2026 14:29 CET

Reference is made to the announcement published 16 March 2026 regarding Aker
BioMarine ASA exercising its call option to redeem all outstanding bonds under
its senior secured bond issue “FRN Senior Secured NOK 2,000,000,000 Bonds
2024/2027” (ISIN NO0013326025). The exercise of the call option was conditional
on satisfaction of the conditions precedent for utilisation of a new credit
facility agreement in an amount sufficient to redeem the outstanding bonds. We
are pleased to confirm that the conditions have been satisfied and that all
outstanding bonds will be redeemed as set out in announcement published 16 March
2026. The entire bond issue will be repaid at a price equal to 102.125% of the
nominal amount for each redeemed bond plus accrued interest, with record date on
26 March 2026 and call option repayment date on 30 March 2026. The confirmation
from Nordic Trustee AS to the bondholders is attached.

For any questions, please contact:

For further information, please contact
Katrine Klaveness, CFO
Mobile: +47 991 58 915
Email: Katrine.klaveness@akerbiomarine.com

This information is subject to the disclosure requirements pursuant to MAR
Article 19 and Section 5-12 of the Norwegian Securities Trading Act.

About Aker BioMarine:
Aker BioMarine is a leading human health and nutrition innovator that develops
krill-derived products for consumer health and nutrition. Krill is a natural,
powerful, and health-promoting source of nutrients from the pristine waters of
Antarctica, and Aker BioMarine has a unique position in its industry. The
ingredient portfolio consists of Superba Krill Oil, Lysoveta, Revervia, and PL+,
as well as the consumer brand, Kori Krill. The innovative approach also extends
into the spin-offs AION (reduce and recycle plastic waste across industries) and
Understory (a protein brand). Aker BioMarine is listed on the Oslo Stock
Exchange (AKBM). More information is available at www.akerbiomarine.com.

More information:
Access the news on Oslo Bors NewsWeb site

669304_NO0013326025_IB_20260325.pdf